UK prevention guidelines have not reduced group B Strep infections in newborn babies in the UK and Republic of Ireland
Data from the latest enhanced surveillance study into group B Strep infection showed a rise of 51% in the number of these infections in babies aged 0-90 days, and a 31% rise in the rate per 1,000 live births in the UK and Republic of Ireland in 2014 compared with 2001 (to 0.94 from 0.72 per 1,000 live births). Read a summary of the 2014-5 study here, and a summary of the 2000-1 study here.
Although the number of babies who sadly died from their group B Strep infection was no higher in 2014 than in 2000 (53), more than twice as many of the survivors in 2014 were reported as having major, minor or possible disability at discharge (71) compared with 2000.
So, on average:
- 2 babies a day develop GBS infection
- 1 baby a week dies from GBS infection and
- 1 baby a week survives with long-term disability
These increases are particularly shocking since in between these two extensive studies the Royal College of Obstetricians & Gynaecologists introduced their risk-based prevention guidelines in 2003. These guidelines had been expected to effect a fall in early onset (0-6 days) GBS infections by 50-60%.
The potentially preventable early-onset group B Strep infections (in babies aged 0-6 days) are shown in the blue bar. It is these that the risk-based prevention strategy had been expected to reduce.
The rate of late-onset group B Strep infections (in babies aged 7-90 days), shown in the red bar, has also increased. Sadly, these cannot currently be prevented.
In the future, a GBS vaccine will be developed to prevent most group B Strep infection – early and late onset, as well as stillbirths and maternal infections – but this is still many years away. More needs to be done now to prevent GBS infections in babies.
In countries that screen routinely for group B Strep, such as the United States, the incidence has fallen dramatically since the introduction of prevention strategies:
US Data Image reference: adapted from Jordan HT, Farley MM, Craig A, et al. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease. Pediatr Infect Dis J 2008;27:1057-64.
As the graph shows very clearly, intravenous antibiotics given in labour against group B Strep infection have been hugely effective at reducing the incidence of early-onset group B Strep infection, but have had no impact on late-onset group B Strep infection. The rate in the US has fallen still further after 2008. For 2014, the US rate for early onset GBS infection was 0.24 per 1,000 live births and for late onset 0.27 (click here). For 2014-5 in the UK and Republic of Ireland, the rates were 0.57 for early-onset and 0.37 for late onset per 1,000 live births respectively.
For the data series published by Public Health England and its predecessors on the incidence of GBS bacteraemia (GBS detected from the blood) from 2001 onwards, please click here.